Table 1.
Demographics and disease characteristics in the decreased/stable uric acid and increased uric acid groups.
| Variables | Uric Acid | p | |
|---|---|---|---|
| Decreased/Stable | Increased | ||
| (n = 675) | (n = 230) | ||
| Age, years, mean ± SD | 57 + 15.4 | 58 + 16 | 0.4734 |
| Gender, n (%) | 0.0393 | ||
| Female | 253 (37.5) | 69 (30.0) | |
| Male | 421 (62.5) | 161 (70.0) | |
| Race, n (%) | 0.8273 | ||
| Caucasian | 373 (55.3) | 129 (56.1) | |
| Other | 302 (44.7) | 101 (43.9) | |
| Smoking History, n (%) | 423 (62.7) | 149 (64.8) | 0.7366 |
| BMI, kg/m2, mean ± SD | 27.5 + 4.7 | 28.5 + 6.0 | 0.0201 |
| History of DM, n (%) | 148 (21.9) | 62 (27.0) | 0.1186 |
| History of HTN, n (%) | 412 (61.0) | 150 (65.2) | 0.2591 |
| Statin Medications, n (%) | 188 (27.9) | 42 (18.3) | 0.0039 |
| ASA Class, n (%) | 0.0662 | ||
| 2 | 264 (42.3) | 78 (35.6) | |
| 3 | 282 (45.1) | 101 (46.1) | |
| 4 | 79 (12.6) | 40 (18.3) | |
| AJCC Clinical Stage, n (%) | <0.001 | ||
| I | 473 (70.1) | 127 (55.2) | |
| II | 128 (19.0) | 46 (20.0) | |
| III | 67 (9.9) | 41 (17.8) | |
| IV | 7 (1.0) | 16 (7.0) | |
| Pathology, n (%) | 0.0986 | ||
| Clear Cell | 510 (75.6) | 186 (80.9) | |
| Other | 165 (24.4) | 44 (19.1) | |
| Surgery Type, n (%) | 0.0002 | ||
| Radical | 432 (64.0) | 178 (77.4) | |
| Partial | 243 (36.0) | 52 (22.6) | |
| Preop SUA | 5.45 +2.13 | 5.59 + 1.243 | 0.345 |
| Postop SUA | 5.173 +1.21 | 6.42 +1.20 | <0.001 |
BMI, Body mass index; DM, Diabetes mellitus; HTN, hypertension; ASA, American society of Anaesthesiologists’ physical status classification; AJCC, American Joint Committee on Cancer.